Development of fentanyl-specific monoclonal antibody (mAb) to antagonize the pharmacological effects of fentanyl

In conclusion, mAb passive immunization represents a viable strategy for addressing fentanyl addiction and overdose.PMID:38570042 | DOI:10.1016/j.taap.2024.116918

Source: Toxicology and Applied Pharmacology - April 3, 2024 Category: Toxicology Authors: Xiao-Yi Chen Li Wang Xiao Ma Fan Yang Xiao Wang Peng Xu Li-Li Xu Bin Di Source Type: research